Triamterene in Lithium-induced Nephrogenic Diabetes Insipidus: a Case Report

Overview

Journal CEN Case Rep

Specialty Nephrology

Date 2020 Aug 11

PMID 32772236

Authors

Megumi Inoue

Kentaro Nakai

Koji Mitsuiki

Affiliations

Soon will be listed here.

Abstract

Lithium-induced nephrogenic diabetes insipidus (NDI) is a rare and difficult-to-treat condition. We describe the case of an 81-year-old woman with bipolar treated with lithium and no previous history of diabetes insipidus. She was hospitalized due to disturbance of consciousness and was diagnosed with, hypercalcemia, hyperparathyroidism, and NDI. Parathyroidectomy was contraindicated and parathyroid hormone level was improved insufficiently after cinacalcet initiation, percutaneous ethanol injection therapy was performed for the enlarged parathyroid gland. After improvement in hypercalcemia and unsuccessful indapamide treatment, triamterene was administrated to control polyuria. Lithium is one of the indispensable maintenance treatment options for bipolar disorder, but it has the side effect of NDI. Lithium enters the collecting duct's principal cells mainly via the epithelial sodium channel (ENaC) located on their apical membranes, ENaC shows high selectivity for both sodium and lithium, is upregulated by aldosterone, and inhibited by triamterene. To our knowledge, this is the first publication on triamterene use in lithium-induced NDI patients.

References

Bichet D, Bockenhauer D . Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab. 2016; 30(2):263-76. DOI: 10.1016/j.beem.2016.02.010. View

Nielsen S, Frokiaer J, Marples D, Kwon T, Agre P, Knepper M . Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002; 82(1):205-44. DOI: 10.1152/physrev.00024.2001. View

Rojek A, Nielsen J, Brooks H, Gong H, Kim Y, Kwon T . Altered expression of selected genes in kidney of rats with lithium-induced NDI. Am J Physiol Renal Physiol. 2005; 288(6):F1276-89. DOI: 10.1152/ajprenal.00305.2004. View

Thomsen K, Shirley D . A hypothesis linking sodium and lithium reabsorption in the distal nephron. Nephrol Dial Transplant. 2006; 21(4):869-80. DOI: 10.1093/ndt/gfk029. View

Macleod M, Bell G, Irvine W . Nephrogenic diabetes insipidus associated with Dyazide (triamterene-hydrochlorothiazide). Br Med J (Clin Res Ed). 1981; 283(6300):1155-6. PMC: 1507346. DOI: 10.1136/bmj.283.6300.1155. View

Halenka M, Frysak Z, Koranda P, Schovanek J . ULTRASOUND-GUIDED PERCUTANEOUS ETHANOL INJECTION THERAPY IN A 92 YEAR-OLD PATIENT WITH PARATHYROID ADENOMA AND WITH A HISTORY OF TOTAL THYROIDECTOMY FOR PAPILLARY THYROID CARCINOMA. Acta Endocrinol (Buchar). 2019; 12(3):349-354. PMC: 6535268. DOI: 10.4183/aeb.2016.349. View

Kellenberger S, Schild L . Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev. 2002; 82(3):735-67. DOI: 10.1152/physrev.00007.2002. View

Hestbech J, Hansen H, Amdisen A, Olsen S . Chronic renal lesions following long-term treatment with lithium. Kidney Int. 1977; 12(3):205-13. DOI: 10.1038/ki.1977.102. View

Kwon T, Laursen U, Marples D, MAUNSBACH A, Knepper M, Frokiaer J . Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI. Am J Physiol Renal Physiol. 2000; 279(3):F552-64. DOI: 10.1152/ajprenal.2000.279.3.F552. View

10.

Kavanagh C, Uy N . Nephrogenic Diabetes Insipidus. Pediatr Clin North Am. 2018; 66(1):227-234. DOI: 10.1016/j.pcl.2018.09.006. View

11.

de Groot T, Sinke A, Kortenoeven M, Alsady M, Baumgarten R, Devuyst O . Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus. J Am Soc Nephrol. 2015; 27(7):2082-91. PMC: 4926986. DOI: 10.1681/ASN.2015070796. View

12.

Timmer R, Sands J . Lithium intoxication. J Am Soc Nephrol. 1999; 10(3):666-74. DOI: 10.1681/ASN.V103666. View